RVPH vs. ELV
RVPH (Reviva Pharmaceuticals Holdings, Inc.) and ELV (Elevance Health, Inc.) are both stocks. Both are in the Healthcare sector — RVPH in Biotechnology, ELV in Healthcare Plans. Over the past 5 years, RVPH returned -63.76%/yr vs 1.01%/yr for ELV. Their 0.05 correlation means their historical movements had little consistent relationship.
Performance
RVPH vs. ELV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RVPH achieves a -92.15% return, which is significantly lower than ELV's 8.31% return.
RVPH
- 1D
- 0.08%
- 1M
- -33.66%
- 6M
- -92.51%
- YTD
- -92.15%
- 1Y
- -94.97%
- 3Y*
- -83.40%
- 5Y*
- -63.76%
- 10Y*
- —
- ALL TIME*
- -54.26%
ELV
- 1D
- -0.15%
- 1M
- -10.06%
- 6M
- 9.82%
- YTD
- 8.31%
- 1Y
- 39.71%
- 3Y*
- -5.51%
- 5Y*
- 1.01%
- 10Y*
- 13.15%
- ALL TIME*
- 13.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $467.14M | $602.22M | $657.78M | |
| $28.52K | $31.29K | $163.05K |
RVPH vs. ELV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
RVPH Reviva Pharmaceuticals Holdings, Inc. | -92.15% | -84.59% | -64.85% | 21.18% | 47.06% | -66.95% | -16.40% | 6.19% | 2.07% |
ELV Elevance Health, Inc. | 8.31% | -3.14% | -20.72% | -6.89% | 11.83% | 46.12% | 7.74% | 16.33% | -5.82% |
Correlation
The correlation between RVPH and ELV is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.07 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2018 | 0.05 |
Fundamentals
RVPH:
$5.74M
ELV:
$81.51B
RVPH:
-$4.17M
ELV:
$22.41
RVPH:
0.18
ELV:
1.82
RVPH:
$0.00
ELV:
$201.11B
RVPH:
$0.00
ELV:
$78.34B
RVPH:
-$20.20T
ELV:
$8.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RVPH vs. ELV — Risk / Return Rank
RVPH
ELV
RVPH vs. ELV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and Elevance Health, Inc. (ELV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RVPH | ELV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.58 | ||
| Sortino ratioReturn per unit of downside risk | -2.55 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.21 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.35 | -2.32 |
| Martin ratioReturn relative to average drawdown | -1.37 | 3.46 | -4.83 |
Loading charts...
Drawdowns
RVPH vs. ELV - Drawdown Comparison
The maximum RVPH drawdown since its inception was -99.86%, which is greater than ELV's maximum drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for RVPH and ELV.
Loading charts...
Drawdown Indicators
| RVPH | ELV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -67.19% | -32.67% |
Max Drawdown (1Y)Largest decline over 1 year | -98.02% | -26.49% | -71.53% |
Max Drawdown (3Y)Largest decline over 3 years | -99.72% | -50.38% | -49.34% |
Max Drawdown (5Y)Largest decline over 5 years | -99.81% | -50.38% | -49.43% |
Max Drawdown (10Y)Largest decline over 10 years | — | -50.38% | — |
Current DrawdownCurrent decline from peak | -99.82% | -30.68% | -69.14% |
Average DrawdownAverage peak-to-trough decline | -56.36% | -15.36% | -41.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 69.31% | 10.32% | +58.99% |
Volatility
RVPH vs. ELV - Volatility Comparison
Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a higher volatility of 39.01% compared to Elevance Health, Inc. (ELV) at 12.46%. This indicates that RVPH's price experiences larger fluctuations and is considered to be riskier than ELV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RVPH | ELV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 39.01% | 12.46% | +26.55% |
Volatility (6M)Calculated over the trailing 6-month period | 148.04% | 25.13% | +122.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 167.77% | 35.60% | +132.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 130.94% | 29.66% | +101.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.39% | 31.09% | +83.30% |
Dividends
RVPH vs. ELV - Dividend Comparison
RVPH has not paid dividends to shareholders, while ELV's dividend yield for the trailing twelve months is around 1.83%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELV Elevance Health, Inc. | 1.83% | 1.95% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% |
RVPH Reviva Pharmaceuticals Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RVPH vs. ELV - Financials Comparison
This section allows you to compare key financial metrics between Reviva Pharmaceuticals Holdings, Inc. and Elevance Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RVPH and ELV have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RVPH has higher volatility (39.01%) compared to ELV (12.46%). In terms of maximum drawdown, RVPH dropped -99.86% vs ELV's -67.19%.
ELV currently has the higher Sharpe Ratio (1.01 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RVPH and ELV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer